Opus Genetics, Inc. (NASDAQ: IRD) reported Q1 EPS of ($0.75), $0.62 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $2.16 million versus the consensus estimate of $3.16 million.

For earnings history and earnings-related data on Opus Genetics, Inc. (IRD) click here.